Terms: = Liver cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
12 results:
1. [JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA malat1 in exosomes].
Xu M; Shi Y; Liu J; Wu M; Zhang F; He Z; Tang M
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1525-1535. PubMed ID: 37814867
[TBL] [Abstract] [Full Text] [Related]
2. malat1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
Matuszyk J
Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
[TBL] [Abstract] [Full Text] [Related]
3. lncRNA malat1 promotes HCC metastasis through the peripheral vascular infiltration via miRNA-613: a primary study using contrast ultrasound.
Zhou D; Wang Y; Hu H; Liu H; Deng J; Li L; Zheng C
World J Surg Oncol; 2022 Jun; 20(1):203. PubMed ID: 35706002
[TBL] [Abstract] [Full Text] [Related]
4. Intelligent Bio-Responsive Fluorescent Au-shRNA Complexes for Regulated Autophagy and Effective cancer Bioimaging and Therapeutics.
Cai W; Yin L; Jiang H; Weizmann Y; Wang X
Biosensors (Basel); 2021 Oct; 11(11):. PubMed ID: 34821640
[TBL] [Abstract] [Full Text] [Related]
5. An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA malat1 in the Regulation of Lipid Metabolism.
Wang H; Zhang Y; Guan X; Li X; Zhao Z; Gao Y; Zhang X; Chen R
Mol Cell Proteomics; 2021; 20():100141. PubMed ID: 34478876
[TBL] [Abstract] [Full Text] [Related]
6. malat1: A Promising Therapeutic Target for the treatment of Metastatic Colorectal cancer.
Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA malat1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H
Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597
[TBL] [Abstract] [Full Text] [Related]
8. Targeting the Epigenetic Non-Coding RNA malat1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
Chang HL; Bamodu OA; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Apr; 9(4):. PubMed ID: 32326045
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of malat1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
[TBL] [Abstract] [Full Text] [Related]
10. The HIF-2α-malat1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
[TBL] [Abstract] [Full Text] [Related]
11. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate cancer.
Alahari SV; Eastlack SC; Alahari SK
Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
[TBL] [Abstract] [Full Text] [Related]
12. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
[TBL] [Abstract] [Full Text] [Related]
